ArticleInternational wound journal2024
RETRACTED: A meta-analysis on the impact of spinal cord stimulation on post-operative wound healing in patients with multiple sclerosis.
Article in International wound journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- RETRACTION: A Meta-Analysis on the Impact of Spinal Cord Stimulation on Post-Operative Wound Healing in Patients With Multiple Sclerosis.International wound journal · 2025Article
- RETRACTED: A meta-analysis on the impact of spinal cord stimulation on post-operative wound healing in patients with multiple sclerosis.International wound journal · 2024Article
Corrections and comments
- Retracted
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal cord stimulation (SCS) has emerged as a potential therapeutic tool for various chronic conditions, but its efficacy in post-operative wound healing for multiple sclerosis (MS) patients has not been comprehensively understood. This meta-analysis aimed to evaluate the impact of SCS on post-operative wound healing and scar formation in MS patients. A systematic literature review identified seven studies for inclusion. We focused on wound healing as measured by the redness, edema, ecchymosis, discharge, approximation (REEDA) scale 1 week post-operation and scar formation assessed by the Manchester Scar Scale (MSS) 3 months post-operation. The results demonstrated a significant improvement in wound healing in the SCS group, with a standard mean difference (SMD) of -5.82 (95% confidence interval [CI]: [-7.56, -4.09], p < 0.01) on the REEDA scale. For scar formation, the SCS group showed a notable reduction in MSS scores, with an SMD of -10.06 (95% CI: [-14.53, -5.58], p < 0.01). These findings underscore the potential of SCS as an adjunct therapy in enhancing surgical recovery in MS patients, pointing towards its broader applications in post-operative care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.